It was reported that the procedure was to treat a moderately tortuous, mildly calcified de novo left superficial femoral artery.The supera stent was advanced to the lesion.The lesion was prepped with a 6.5mm balloon inflating it for 2 minutes.During deployment, the deployment lock was unlocked and the thumb slide advanced to the most distal position on the handle, however, the stent only partially deployed (1cm) as the thumbslide was difficult to move forward.It was decided to remove the device and another supera was used to successfully complete the procedure.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
|
The device was returned for analysis.The reported mechanical jam and the reported activation failure was unable to be confirmed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.As there was no reported damage noted to the device during the inspection prior to use, it is possible that interaction with the moderately tortuous and mildly calcified anatomy resulted in the ratchet being unable to properly engage and release the stent from the delivery system thus resulting in reported activation failure/ deployment failure and the reported mechanical jam; however this cannot be confirmed.The investigation determined a conclusive cause for the reported activation failure and the reported mechanical jam cannot be determined.Interaction/manipulation of the device likely resulted in the noted device damages (multiple pinched sheath, bunched tip jacket, wrinkled tip jacket/inner member, twisted/split/torn stem, broken ratchet braiding) likely contributing to the reported difficulties.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
|